“…Importantly, SHANK3 mutations have been shown to account for ∼1% of all ASD cases (Leblond et al, 2014). Multiple lines of Shank3 -mutant mice and, more recently, rats that carry global, conditional and point mutations in Shank3 , have been generated and characterized, providing information about normal and disease-related functions of Shank3 (Bozdagi et al, 2010; Peca et al, 2011; Wang et al, 2011; Schmeisser et al, 2012; Yang et al, 2012; Han et al, 2013; Kouser et al, 2013; Lee et al, 2015; Speed et al, 2015; Jaramillo et al, 2016, 2017; Mei et al, 2016; Wang et al, 2016; Zhou et al, 2016; Harony-Nicolas et al, 2017; Vicidomini et al, 2017; Amal et al, 2018; Berg et al, 2018; Bey et al, 2018; Drapeau et al, 2018; Engineer et al, 2018; Fourie et al, 2018; Heise et al, 2018; Jin et al, 2018; Ma et al, 2018; Qin et al, 2018; Yoo et al, 2018; Zhu et al, 2018; Balaan et al, 2019; Rendall et al, 2019). These animals display diverse synaptic, neuronal, circuit and behavioral abnormalities, providing substantial insight into how Shank3 mutations lead to various phenotypic abnormalities in mice (Jiang and Ehlers, 2013; Harony-Nicolas et al, 2015; Sala et al, 2015; Ferhat et al, 2017; Monteiro and Feng, 2017; Mossa et al, 2017; Tan and Zoghbi, 2018).…”